To determine the extent of mitochondrial DNA (mtDNA) damage in systemic lupus erythematosus (SLE) patients compared to healthy subjects and to determine the factors associated with mtDNA damage among SLE patients.
Methods
A cross-sectional study was performed in 86 SLE patients (per American College of Rheumatology classification criteria) and 86 healthy individuals matched for age and gender. Peripheral blood mononuclear cells (PBMCs) were collected from subjects to assess the relative amounts of mtDNA damage. Quantitative polymerase chain reaction assay was used to measure the frequency of mtDNA lesions and mtDNA abundance. Socioeconomic-demographic features, clinical manifestations, pharmacologic treatment, disease activity, and damage accrual were determined. Statistical analyses were performed using t test, pairwise correlation, and Pearson’s chi-square test (or Fisher’s exact test) as appropriate.
Results
Among SLE patients, 93.0% were women. The mean (SD) age was 38.0 (10.4) years and the mean (SD) disease duration was 8.7 (7.5) years. SLE patients exhibited increased levels of mtDNA damage as shown by higher levels of mtDNA lesions and decreased mtDNA abundance as compared to healthy individuals. There was a negative correlation between disease damage and mtDNA abundance and a positive correlation between mtDNA lesions and disease duration. No association was found between disease activity and mtDNA damage.
Conclusion
PBMCs from SLE patients exhibited more mtDNA damage compared to healthy subjects. Higher levels of mtDNA damage were observed among SLE patients with major organ involvement and damage accrual. These results suggest that mtDNA damage have a potential role in the pathogenesis of SLE.
Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol 2013 Oct 8. doi: 10.1038/nrrheum.2013.147.
6.
GergelyPJrGrossmanCNilandB. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum2002; 46: 175–90.
7.
BoverisAChanceB. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J1973; 134: 707–16.
8.
PerlAGergelyPJrNagyGKonczABankiK. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol2004; 25: 360–7.
9.
KesarwaniPMuraliAKAl-KhamiAAMehrotraS. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal2013; 18: 1497–534.
PerlAGergelyPJrBankiK. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. Int Rev Immunol2004; 23(3–4): 293–313.
12.
NagyGBarczaMGonchoroffNPhillipsPEPerlA. Nitric oxide-dependent mitochondrial biogenesis generates Ca2 signaling profile of lupus T cells. J Immunol2004; 173: 3676–83.
13.
ClaytonDA. Transcription of the mammalian mitochondrial genome. Annu Rev Biochem1984; 53: 573–94.
14.
AttardiG. The elucidation of the human mitochondrial genome. Bioessays1986; 5: 34–9.
15.
YakesFMVan HoutenB. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A1997; 94: 514–9.
16.
VyshkinaTSylvesterASadiqS. Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus. Clin Immunol2008; 129: 31–5.
17.
JönsenAYuXTruedssonL. Mitochondrial DNA polymorphisms are associated with susceptibility and phenotype of systemic lupus erythematosus. Lupus2009; 18: 309–12.
18.
JiangXChenF. The effect of lipid peroxides and superoxide dismutase on systemic lupus erythematosus: a preliminary study. Clin Immunol Immunopathol1992; 63: 39–44.
19.
GruneTMichelPSitteN. Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med1997; 23: 357–60.
20.
KurienBTScofieldRH. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci2003; 73: 1655–66.
21.
MansourRBLassouedSGargouriBEl GaïdAAttiaHFakhfakhF. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol2008; 37: 103–8.
22.
ShahDKiranRWanchuABhatnagarA. Oxidative stress in systemic lupus erythematosus: Relationship to Th1 cytokine and disease activity. Immunol Lett2010; 129: 7–12.
23.
IulianoLPraticòDFerroD. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood1997; 90: 3931–5.
24.
AvalosIChungCPOeserA. Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus2007; 16: 195–200.
25.
MorganPESturgessADDaviesMJ. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum2005; 52: 2069–79.
26.
MorganPESturgessADDaviesMJ. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res2009; 43: 117–27.
27.
ShahDSahSWanchuAWuMXBhatnagarA. Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus. Immunobiology2013; 218: 620–7.
28.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–7.
29.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
30.
UribeAGViláLMMcGwinGJrSanchezMLReveilleJDAlarcónGS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol2004; 31: 1934–40.
31.
LiangMHSocherSALarsonMGSchurPH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum1989; 32: 1107–18.
32.
LiangMHFortinPRIsenbergDASnaithL. Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda. Rheumatol Int1991; 11: 133–6.
33.
GladmanDDGoldsmithCHUrowitzMB. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol2000; 27: 373–6.
34.
CastroMdelRSuarezEKraiselburdE. Aging increases mitochondrial DNA damage and oxidative stress in liver of rhesus monkeys. Exp Gerontol2012; 47: 29–37.
35.
SiddiquiARivera-SánchezSCastroMdelR. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease. Free Radic Biol Med2012; 53: 1478–88.
36.
Ayala-TorresSChenYSvobodaTRosenblattJVan HoutenB. Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction. Methods2000; 22: 135–47.
37.
WangGPierangeliSSPapalardoEAnsariGAKhanMF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum2010; 62: 2064–72.
38.
BashirSHarrisGDenmanMABlakeDRWinyardPG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Annals of the Rheumatic Diseases1993; 52: 659–66.
39.
LunecJHerbertKBlountSGriffithsHREmeryP. 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett1994; 348: 131–8.
40.
EmlenWNieburJKaderaR. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol1994; 152: 3685–92.
41.
WallaceSS. Biological consequences of free radical-damaged DNA bases. Free Radic Biol Med2002; 33: 1–14.
TannAWBoldoghIMeissG. Apoptosis induced by persistent single-strand breaks in mitochondrial genome. J Biol Chem2011; 286: 31975–83.
44.
FurdaAMMarrangoniAMLokshinAVan HoutenB. Oxidants and not alkylating agents induce rapid mtDNA loss and mitochondrial dysfunction. DNA Repair (Amst)2012; 11: 684–92.
45.
LeeH-TLinCSChenWSLiaoHTTsaiCYWeiYH. Leukocyte mitochondrial DNA alteration in systemic lupus erythematosus and its relevance to the susceptibility to lupus nephritis. Int J Mol Sci2012; 13: 8853–68.
46.
LeeHMSuginoHAokiCNishimotoN. Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosus. Arthritis Res Ther2011; 13: R63–R63.
47.
CorderoMDDe MiguelMMoreno FernándezAM. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther2010; 12: R17–R17.
48.
CorderoMDDe MiguelMCarmona-LópezIBonalPCampaFMoreno-FernándezAM. Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol Lett2010; 31: 169–73.
49.
KurienBTScofieldRH. Lipid peroxidation in systemic lupus erythematosus. Indian J Exp Biol2006; 44: 349–56.
50.
HassanSZGheitaTAKenawySAFahimATEl-SorougyIMAbdouMS. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis2011; 14: 325–31.
51.
ShahDWanchuABhatnagarA. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology2011; 216: 1010–7.
